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Abstract 
Purpose: To investigate the potency of ampicillin in altering gut flora in the presence of a high-sucrose 
diet in rat pups, and to determine its effect on selected neurotransmitters and a cytokine as markers of 
the persistent autistic features repeatedly induced in orally administered propionic acid rat pups.. 
Methods: Twenty-eight young male Wistar albino rats were divided into four equal groups. The first 
group served as a control. The second group received an oral neurotoxic dose of propionic acid (PPA, 
250 mg/kg body weight/day) for 3 days. The third group was treated with ampicillin (50 mg/kg for 3 
weeks) with a standard diet. The fourth group was given the same dose of ampicillin with a high-sucrose 
diet for 10 weeks.  
Results: The results showed a significant (p < 0.001) decrease in the investigated neurotransmitters in 
PPA- and ampicillin-treated rat pups (norepinephrine by 32.49 and 14.58 %, dopamine by 31.45 and 
20.22 %, serotonin by 35.99 and 29.09 %), as well as a remarkable increase (p < 0.001) in the pro-
inflammatory cytokine, IL-6 (30.07and 6.07 %). The high-sucrose diet also significantly (p < 0.001) 
enhanced the neurotoxic effect of ampicillin. 
Conclusion: The observed dietary modulation of the gut microbiota, coupled with the subsequent 
modulation of brain neurochemistry and inflammation, demonstrates the considerable potential of 
dietary intervention through the elimination of highly refined sugar as a treatment strategy to prevent 
and treat autism.  
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Antibiotics are prescribed frequently for infants 
and children in nearly all pediatric clinics 
[1].Antibiotic treatment over a long period results 
in a 10-fold increase of Clostridium spp 
(propionibacteria) in the gut. Overgrowth of this 
species has also been reported in autistic 
patients [2].Furthermore, the induction of 
persistent autistic features in rodent modelswas 
achieved by MacFabe et al [3] and El-Ansary et 
al [4] through propionic acid (PPA) exposure. A 
concomitant increase in the fecal concentrations 
of PPA in children with autism may indicate the 
role by which microbial metabolites alter brain 
function through the gut–brain axis. It is now 
acknowledged that the gut–brain axis and 
balanced gut microbiota are critically important 
during brain development and can play a major 
role in the pathogenesis of autism. In the gut, 
several members of the Bifidobacterium and 
Lactobacillus genera have been found to 
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possess health-promoting properties and are 
affected by diet, whereas many Proteobacteria 
have the potential to become pathogenic when a 
suitable environment is provided. Due to 
immature renal function and blood brain barrier, 
ampicillin is neurotoxic in very low birth weight 
neonates, resulting in a remarkable increase of 
ampicillin in both serum and CSF [5]. Ampicillin is 
believed to exert an inhibitory effect on GABA 
transmission [6]. Imbalances in 
GABAergic/glutamatergic, serotonergic, and 
dopaminergic neurotransmission together with 
neuroinflammation were recently reported as the 
most important signals related to the clinical 
presentation and severity of autism [7]. 
 
This information motivated our interest to 
compare the gut–brain neurotoxic effect of 
ampicillin to that induced by orally administered 
PPA as a metabolic end-product of 
propionibacteria. The impact of a high-refined-
sugar diet on the neurochemical effects induced 






The study included 28 male Wistar albino rats 
divided into four independent groups containing 
seven rats each. Group I served as the control 
and received only phosphate buffered saline; 
Group II was administered with PPA (250 mg/kg 
body weight/day) for three days [4]; Group III was 
treated with an oral dose of ampicillin (50 mg/kg 
for three weeks) with a standard diet; and Group 
IV was given the same dose of ampicillin with a 
high-sucrose diet for 10 weeks. The study was 
approved by the Ethics Committee of King Saud 
University with approval no.KSU-IRB008E. 





The special diet characterized by high sugar was 
made by mixing sucrose with regular chow. 
 
Sample preparation   
 
Brain tissue was homogenized in 10 times w/v bi-
distilled water and was used to measure all 
parameters evaluated in the study. 
 
Assay for neurotransmitters (NA, DA and 
5HT) 
 
High-performance liquid chromatography with 
electrochemical detection was used to measure 
dopamine, serotonin and norepinephrine [9].  
IL-6 assay 
 
IL-6 was assayed using a Quantikine ELISA kit 
(R & D Systems, Minneapolis, MN, USA). A 
microplate was pre-coated with a monoclonal 
antibody specific for rat IL-6. 
 
Glutamine and glutamate assays 
 
Rat brain glutamine and glutamate were 





Fecal samples were used to identify the gut 
bacteria by culturing the samples under aerobic 
and anaerobic conditions. All the species found 
were identified using Scepter micro dilution and 




SPSS (Chicago,IL, USA) was used to analyze 
the data by using ANOVA for one-way analysis 
of variance and Dunnett test for multiple 
comparisons. P values less than 0.05 were 
considered significant. Receiver operating 
characteristics curve (ROC) analysis was 
performed to test the predictive value of the 
investigated parameters and to measure the 
toxicity of PPA and ampicillin in intoxicated rats. 
An area under the curve (AUC) of 0.8-1 indicated 
an excellent predictive value for the biomarker. 
This was accompanied by satisfactory values for 
sensitivity and specificity. Pearson’s correlation 
analysis was also performed using the same 
SPSS program. Multiple regression analysis was 
conducted using glutamate and IL-6 as two 
dependent variables against the rest of the 





Ampicillin treatment for six weeks altered the gut 
flora, resulting in unusual growth of a few PPA 
producers (e.g., Klebsiella pneumonia and 
Proteus vulgaris), while some species, such as 
Enterobacter cloacae, vanished. Ampicillin also 
promoted the overgrowth of Candida albicans. 
 
Table 1 and Figure 1 show the significant 
changes in the brain chemistry of rats treated 
with PPA and ampicillin, as well as changes in 
those fed a high sucrose diet for 10 weeks post 
antibiotic treatment. NA was significantly reduced 
in both PPA and ampicillin-treated groups by 
32.49 % and 14.58 %, respectively. However, the 
high-sucrose diet in ampicillin-treated rats was 
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the most potent, as it induced a 43.11 % 
decrease in NA in the brain. The three groups 
differed from the control (p ˂ 0.001). However, 
PPA induced the most significant decrease in DA 
and 5HT. 
 
Regarding the excitotoxicity presented by 
glutamate, PPA was the most potent, as it 
induced a 56.3 % increase, followed by the other 
two groups, which demonstrated a 23.55 and 
17.75 % increase, respectively. The glutamine 
level was equally affected in the different 
treatments, showing an approximately 35 % 
increase at p ˂ 0.013. The glutamate/glutamine 
ratio showed a non-significant difference 
compared to the control (Figure 1 and Table 2). 
 
IL-6 was remarkably elevated in all experimental 
groups compared to that of the control. PPA and 
a HSD induced similar increases in IL-6 (30 % 
and 27 %, respectively), which were noticeably 
higher than that in ampicillin-treated animals 
(6.07 %) (Table 1 and Figure 1). 
 
 
Table 1: Biochemical parameters of PPA, ampicillin-treated and ampicillin/HSD-fed rats  
 
Parameter Group N Mean ± S.D. Percent change P-value 
NA 
Control 7 6.92 ± 0.78 100.00 
0.001 PPA 7 4.67 ± 0.45 67.51 Ampicillin 7 5.91 ± 0.28 85.42 
HSD 7 3.93 ± 0.45 56.89 
DA 
Control 7 25.95 ± 1.68 100.00 
0.001 PPA 7 17.79 ± 1.34 68.55 Ampicillin 7 20.70 ± 3.37 79.78 
HSD 7 21.46 ± 0.78 82.72 
IL-6 
Control 7 227.34 ± 19.47 100.00 
0.001 PPA 7 295.71 ± 23.92 130.07 Ampicillin 7 241.15 ± 23.26 106.07 
HSD 7 290.22 ± 41.24 127.66 
5-HT 
Control 7 8.59 ± 0.42 100.00 
0.001 PPA 7 5.50 ± 0.66 64.01 Ampicillin 7 6.02 ± 0.51 70.10 
HSD 7 6.03 ± 0.55 70.25 
Glut 
Control 7 237.99 ± 18.93 100.00 
0.007 PPA 7 371.97 ± 105.29 156.30 Ampicillin 7 294.03 ± 57.76 123.55 
HSD 7 280.22 ± 47.12 117.75 
Gln 
Control 7 2169.73 ± 223.94 100.00 
0.013 PPA 7 2930.67 ± 664.56 135.07 Ampicillin 7 2921.69 ± 520.35 134.66 
HSD 7 2967.29 ± 412.29 136.76 
Glut/ Gln 
Control 7 9.15 ± 1.10 100.00 
0.183 PPA 7 8.36 ± 2.80 91.35 Ampicillin 7 10.15 ± 2.02 110.89 
HSD 7 10.82 ± 2.37 118.24 
 
 
Figure 1: Percent change in all measured parameters 
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Table 2: Pearson’s correlation between the measured 
parameters 
 
Parameter R (Pearson’s correlation) P value 
NA ~ DA 0.496 0.007 
NA ~ IL-6 -0.645 0.001 
NA ~ 5-HT 0.678 0.001 
NA ~ Gln -0.556 0.002 
DA ~ IL-6 -0.563 0.002 
DA ~ 5-HT 0.756 0.001 
DA ~ Glut -0.508 0.006 
DA ~ Gln -0.509 0.006 
IL-6 ~ 5-HT -0.610 0.001 
IL-6 ~ Gln 0.563 0.002 
IL-6 ~ Glut/Gln 0.374 0.050 
5-HT ~ Glut -0.466 0.012 
5-HT ~ Gln -0.639 0.001 
Glut ~ Glut/Gln -0.592 0.001 
Gln ~ Glut/Gln 0.545 0.003 
 
Table 2 presents the Pearson’s correlations 
between the measured parameters. It is clear 
that the neuroinflammatory marker IL-6 was 
positively correlated with glutamine and 
glutamate/glutamine ratio and was negatively 
correlated with NA, DA and 5HT. In addition, NA, 
DA and 5HT were positively correlated with each 
other and negatively correlated with glutamate, 
glutamine and glutamate/glutamine ratio. 
 
Table 3 and Figure 2 present the area under the 
curve (AUC), specificity and sensitivity for the 
measured neurotransmitters and for IL-6 in the 
studied groups. 
 
Table 4 shows the results of multiple regression 
analysis using glutamate as a dependent 
variable. It can be easily confirmed that 
glutamate is related to glutamine and the 





As gastrointestinal conditions and eating 
problems are common in autism, diet might 
represent a link between environmental and 
neurobiological factors and thus may play a role 
in the pathways leading to the etiology of this 
disorder. The impact of PPA, ampicillin treatment 
and a high-sucrose diet on the alteration of brain 
chemistry will be discussed. The recorded 
overgrowth of Candida albicans in the gut can be 
easily related to the induced autistic features. 
Yeast feed on sugar and produce alcohol, a toxic 
chemical that can easily be transported in the 
blood to the frontal lobes of the brain, where it  
Table 3: ROC analysis of the measured parameters demonstrating area under the curve (AUC), 
cutoff values, sensitivity and specificity in the three experimental groups. 
 








PPA 1.000 5.420 100.0 100.0 
Ampicillin 0.918 6.365 100.0 85.7 
HCD 1.000 5.220 100.0 100.0 
DA 
PPA 1.000 21.950 100.0 100.0 
Ampicillin 0.918 23.675 85.7 100.0 
HCD 1.000 23.435 100.0 100.0 
IL-6 
PPA 1.000 258.510 100.0 100.0 
Ampicillin 0.673 252.070 42.9 100.0 
HCD 0.959 252.260 85.7 100.0 
5-HT 
PPA 1.000 7.115 100.0 100.0 
Ampicillin 1.000 7.300 100.0 100.0 
HCD 1.000 7.380 100.0 100.0 
Glut 
PPA 1.000 267.650 100.0 100.0 
Ampicillin 0.878 257.650 85.7 85.7 
HCD 0.816 258.140 71.4 85.7 
Gln 
PPA 0.918 2551.090 71.4 100.0 
Ampicillin 0.959 2517.300 85.7 100.0 
HCD 1.000 2514.155 100.0 100.0 
Glut/Gln 
PPA 0.612 7.436 42.9 100.0 
Ampicillin 0.694 9.185 71.4 71.4 
HCD 0.755 9.385 85.7 71.4 
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Figure 2: ROC Curve for all parameters in propinic acid group (A), ampicillin group (B) and ampicillin-
HSD fed group (C) 
 
Table 4: Multiple regression using stepwise method for glutamate as a dependent variable 
 
Predictor variable Beta P-value Adjusted R square 
Model 
F-value P-value 
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inhibits nerve growth and brain development. 
This inhibition often manifests as sugar cravings, 
hyperactivity, irritability, social impairment and 
cognitive disability [10]. 
 
Table 2 and Figure 1 show that PPA, ampicillin 
and a high-refined-sugar (sucrose) diet induce 
noticeable alterations in brain chemistry that 
manifest as a significant decrease or increase in 
almost all the measured neurotransmitters. This 
is related to the gut microbiota changes induced 
either by PPA, ampicillin or highly refined sugar 
during ampicillin treatment. This theory is 
supported by the recent study by Heijtz et al [11], 
who confirmed that after gut microbiota are 
disrupted by multiple factors including antibiotics, 
CNS chemistry is badly affected through the gut–
brain axis. 
 
Imbalances in the composition of gut microbiota 
in PPA or ampicillin-treated rats are observed as 
the overgrowth of K. pneumonia and P. vulgaris, 
which are propionibacteria and inducers of 
propionic acid producers, respectively. The 
concomitant alteration of most of the measured 
neurotransmitters together with the immune 
sequelae presented by the increase of IL-6, as 
shown in Table 2, may contribute to the 
development of persistent autistic features in 
treated rats [12]. 
 
The significant decrease in the concentration of 
NA in the three groups investigated (PPA-
treated, ampicillin-treated and ampicillin-HSD 
fed) demonstrates the neurotoxic effects of PPA, 
ampicillin and HSD, as this neurotransmitter is 
essential for a wide range of CNS tasks and is 
also involved in neuronal growth [13]. NA has 
also been shown to limit neuroinflammation in 
the CNS [14]. This result can also be easily 
related to the significant elevation of IL-6, TNF α, 
and IFN γ in the brain homogenates of PPA-
treated rats [4]. This could provide support for the 
contribution of PPA and ampicillin as 
environmental factors related to altered gut-
microbiota in the pathogenesis of autism. 
 
The remarkable decrease in 5-HT in the three 
groups studied can be easily related to the 
imbalance between inhibitory/excitatory 
transmission reported in autistic patients and 
rodent models of autism [4,15]. 5-HT interacts 
with DA, NE, GABA, and glutamate systems 
[16,17] and is critical for the maturation of the 
GABA phenotype in the ventral spinal cord via 5-
HT1B receptors [16]. Furthermore, an interaction 
between the glutamate receptors mGLU5 and 
the 5-HT2A receptor was shown in mice [17]. 
The remarkable decrease of serotonin level in 
the brain of treated rats can be related to the 
toxic effects of PPA [3] or the association 
between microbiota and serotonin signaling. Both 
the ampicillin-treated and ampicillin-HSD fed 
groups demonstrated altered intestinal 
microbiota composition, which can easily relate 
to the remarkable decrease in serotonin [18].  
 
Table 1 and Figure 1also demonstrate the 
significant decrease of the neurotransmitter DA 
in the three groups studied. This decrease can 
be attributed to the effects of PPA, ampicillin and 
ampicillin-HSD on DA transporters, thus 
increasing DA breakdown. This suggestion can 
find support in the work of Bello et al [19], who 
demonstrated that 20 min of access to 0.3 M 
sucrose for only 6 days results in upregulation of 
the DA membrane transporters and 
downregulation of the DA receptors. 
 
The significant increase in brain glutamate upon 
treatment with PPA can be easily related to ASD 
features. Glutamate excitotoxicity is one of the 
most important mechanisms involved in the 
etiology of autism. The elevation of glutamate, 
the main brain excitatory neurotransmitter, in the 
PPA, ampicillin-treated or ampicillin-HSD groups 
demonstrated excitotoxicity in the three groups 
studied. Elevation of glutamate can find support 
in a previous study [20], which reported that 
decreased GABA, an inhibitory neurotransmitter, 
could alter excitation/inhibition balance and lead 
to less inhibition of glutamatergic inputs in PPA-
treated rat pups.  
 
On the other hand, the significant increase of 
glutamate as a marker of excitotoxicity in 
ampicillin–treated animals contradicts a previous 
report by Rothstein et al. [21]. The report 
declared that several β-lactam antibiotics, to 
which ampicillin belongs, upregulate the 
expression of the glutamate transporter GLT-1 
protein on astrocytes, thus reducing synaptic 
glutamate and contributing to decreased 
glutamate excitotoxicity. This inconsistency can 
be attributed to the substantial variation in the 
doses used. In the present study, 50 mg/kg body 
weight was used with the intention to alter gut 
microbiota and to study the effect of the induced 
overgrowth of PPA-related bacteria. The 
persistent elevation of glutamate in ampicillin-
treated rats fed a high-sucrose diet can be 
supported by the recent report by Kuang et al 
[22]. The study demonstrated that a maternal 
high-sucrose (HS) diet affects behavior and 
hippocampal neurons in the young offspring, 
leading to learning deficits through a significant 
increase in the expression of N-methyl-D-
aspartate (NMDA) receptors. These receptors 
serve as modulators of glutamate synaptic 
transmission, and thus excessive activation can 
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reflect glutamate elevation and the disruption of 
calcium homeostasis, resulting in either apoptotic 
or necrotic neuronal death or both [23]. 
 
The significant increase of glutamine reported in 
the present study with the concomitant decrease 
of glutamate/glutamine ratio in PPA-treated rats 
can be supported by the recent study by Davison 
et al [24]. The authors performed neuroimaging 
using magnetic resonance spectroscopy (MRS) 
and demonstrated glutamine/glutamate elevation 
in the basal ganglia of all propionic acidemia 
patients during stable metabolic conditions. They 
attributed this elevation to the impact of 
hyperammonemia on cerebral brain water due to 
glutamine being osmotically active. The elevation 
of glutamine in ampicillin-treated or ampicillin-
HSD animals can be related to the altered 
microbiota, as presented in Table 1. Growth was 
detected in K. pneumonia, opportunistic 
pathogens known to generate ammonia in 
immune-compromised humans and animals, and 
hyperammonemia, which usually contributes to 
the pathogenesis of this bacterial species and 
clostridia as propionibacteria (not detected with 
the microbiological technique used in the present 
study) [25]. 
 
Table 3 shows the remarkable association 
between the impaired neurotransmitters and 1L-
6. This association demonstrates that both 
neurochemistry alteration and neuroinflammation 
are involved in the neurotoxic effects of PPA and 
ampicillin. The results also confirms the toxic 
effect of HSD during antibiotic treatment. 
 
The results demonstrate the satisfactory AUC, 
specificity and sensitivity of all measured 





The use of ampicillin influences the profile of 
microbiota through gut–brain interactions that 
affect brain neurochemistry and displays the risk 
of inducing biochemical autistic features. The 
remarkable effects of a high-sucrose diet on 
most of the measured parameters show that the 
induction of PPA-related microbial growth 
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